Preclinical characterization of WB737, a potent and selective STAT3 inhibitor, in natural killer/T‐cell lymphoma

Yali Wang(Fujian University of Traditional Chinese Medicine), Jing Tan(Sun Yat-sen University)
MedComm
June 16, 2023
Cited by 4


Related Papers